FDA OKs Portola’s anticoagulant betrixaban for preventing blood clots
Anyone looking for a case that the FDA is lightening its standards for new products should take a hard look at the agency’s approval …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
